(0.80%) 5 277.51 points
(1.51%) 38 686 points
(-0.01%) 16 735 points
(-0.94%) $77.18
(0.35%) $2.58
(-0.79%) $2 347.70
(-3.10%) $30.56
(0.63%) $1 044.50
(-0.17%) $0.921
(-0.49%) $10.49
(-0.05%) $0.785
(0.15%) $90.40
-1.37% $ 1.440
Live Chart Being Loaded With Signals
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies...
Stats | |
---|---|
Dzisiejszy wolumen | 12 560.00 |
Średni wolumen | 132 788 |
Kapitalizacja rynkowa | 13.54M |
EPS | $0 ( 2024-05-13 ) |
Następna data zysków | ( $-0.550 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.720 |
ATR14 | $0.0160 (1.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-13 | Lindborg Stacy | Buy | 112 500 | Stock Option (Right to Buy) |
2024-03-15 | Church Jeffrey Wayne | Buy | 25 000 | Stock Option (Right to Buy) |
2024-03-15 | Anwer Khursheed | Buy | 25 000 | Stock Option (Right to Buy) |
2024-03-15 | Tardugno Michael H | Buy | 12 500 | Stock Option (Right to Buy) |
2024-03-15 | Fritz Frederick J. | Buy | 3 500 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 4 785 167 | Sell: 160 000 |
Imunon, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Imunon, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-720 005 (0.00 %) |
EPS: | $-2.16 |
FY | 2022 |
Przychody: | $500 000 |
Zysk brutto: | $-231 629 (-46.33 %) |
EPS: | $-5.03 |
FY | 2021 |
Przychody: | $500 000 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.83 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Imunon, Inc.
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej